Moors & Cabot, Inc. Danaher Corp Transaction History

Moors & Cabot, Inc.

$1.9 Billion
Q1 2025

A detailed history of Moors & Cabot, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Moors & Cabot, Inc. holds 2,399 shares of DHR stock, worth $453,962. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,399

Previous 2,581 7.05%

Holding current value

$453,962

Previous $592,000 17.06%

% of portfolio

0.03%

Previous 0.03%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$201.62 - $250.59 $36,694 - $45,607	-182 Reduced 7.05%	2,399 $491,000
Q4 2024 Feb 07, 2025	BUY	$226.16 - $274.52 $5,427 - $6,588	24 Added 0.94%	2,581 $592,000
Q3 2024 Nov 08, 2024	BUY	$239.25 - $280.76 $4,067 - $4,772	17 Added 0.67%	2,557 $710,000
Q2 2024 Aug 09, 2024	BUY	$235.51 - $267.98 $73,243 - $83,341	311 Added 13.95%	2,540 $634,000
Q1 2024 May 08, 2024	SELL	$224.58 - $256.19 $3,368 - $3,842	-15 Reduced 0.67%	2,229 $556,000
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $10,735 - $13,521	58 Added 2.65%	2,244 $519,000
Q3 2023 Nov 07, 2023	SELL	$233.08 - $265.59 $84,141 - $95,877	-361 Reduced 14.17%	2,186 $542,000
Q2 2023 Aug 09, 2023	SELL	$224.99 - $256.14 $225,889 - $257,164	-1,004 Reduced 28.27%	2,547 $611,000
Q1 2023 May 04, 2023	SELL	$239.75 - $277.0 $22,536 - $26,038	-94 Reduced 2.58%	3,551 $894,000
Q4 2022 Feb 09, 2023	BUY	$241.42 - $282.29 $178,167 - $208,330	738 Added 25.39%	3,645 $967,000
Q4 2022 Feb 06, 2023	SELL	$241.42 - $282.29 $195,550 - $228,654	-810 Reduced 21.79%	2,907 $771,000
Q3 2022 Nov 07, 2022	SELL	$247.06 - $1507.4 $241,377 - $1.47 Million	-977 Reduced 20.81%	3,717 $960,000
Q2 2022 Aug 08, 2022	BUY	$237.11 - $299.66 $28,453 - $35,959	120 Added 2.62%	4,694 $1.19 Million
Q1 2022 May 13, 2022	BUY	$257.27 - $315.76 $111,140 - $136,408	432 Added 10.43%	4,574 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $5,549 - $6,251	19 Added 0.46%	4,142 $1.36 Million
Q3 2021 Dec 08, 2021	BUY	$272.21 - $332.43 $1.12 Million - $1.37 Million	4,123 New	4,123 $1.25 Million
Q3 2021 Nov 05, 2021	SELL	$272.21 - $332.43 $1.06 Million - $1.3 Million	-3,910 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$225.08 - $271.69 $49,067 - $59,228	218 Added 5.9%	3,910 $1.05 Million
Q1 2021 May 12, 2021	BUY	$212.38 - $245.9 $6,371 - $7,377	30 Added 0.82%	3,692 $832,000
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $7,650 - $8,836	36 Added 0.99%	3,662 $815,000
Q3 2020 Nov 09, 2020	BUY	$177.16 - $215.33 $6,023 - $7,321	34 Added 0.95%	3,626 $781,000
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $85,199 - $117,061	662 Added 22.59%	3,592 $635,000
Q1 2020 May 12, 2020	BUY	$121.39 - $169.05 $2,549 - $3,550	21 Added 0.72%	2,930 $405,000
Q4 2019 Jan 28, 2020	BUY	$133.47 - $153.48 $2,402 - $2,762	18 Added 0.62%	2,909 $445,000
Q3 2019 Oct 22, 2019	BUY	$135.4 - $146.47 $161,532 - $174,738	1,193 Added 70.26%	2,891 $418,000
Q2 2019 Jul 18, 2019	SELL	$124.88 - $143.73 $116,388 - $133,956	-932 Reduced 35.44%	1,698 $243,000
Q1 2019 May 01, 2019	BUY	$97.62 - $132.29 $256,740 - $347,922	2,630 New	2,630 $344,000
Q4 2018 Feb 13, 2019	SELL	$94.85 - $109.54 $950,017 - $1.1 Million	-10,016 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $41,018 - $45,520	418 Added 4.36%	10,016 $1.09 Million
Q2 2018 Aug 14, 2018	SELL	$96.1 - $103.24 $42,764 - $45,941	-445 Reduced 4.43%	9,598 $943,000
Q1 2018 May 18, 2018	SELL	$92.16 - $103.8 $10,782 - $12,144	-117 Reduced 1.15%	10,043 $983,000
Q4 2017 Feb 13, 2018	SELL	$85.26 - $94.62 $3,069 - $3,406	-36 Reduced 0.35%	10,160 $948,000
Q3 2017 Nov 16, 2017	SELL	$79.29 - $88.45 $64,542 - $71,998	-814 Reduced 7.39%	10,196 $870,000
Q2 2017 Aug 15, 2017	BUY	N/A	11,010	11,010 $928,000

Others Institutions Holding DHR

# of Institutions

2,502

Shares Held

559M

Call Options Held

6.75M

Put Options Held

3.37M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $138B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account